Resident Rounds Part III: Plaque on Left Areola of an African-American Woman

June 2014 | Volume 13 | Issue 6 | Features | 767 | Copyright © June 2014


Lindsey Goddard BBA,a Todd Mollet MD,b and Travis Blalock MDb

aUniversity of Oklahoma College of Medicine, Oklahoma City, OK
bUniversity of Oklahoma Department of Dermatology, Oklahoma City, OK

table 2
At 22 month follow-up the BCC recurred clinically and histologically. We plan to treat the recurrence with Mohs surgery.
BCC of the NAC is considered an aggressive form of BCC.5 In comparison to the overall BCC metastatic rate of less than 0.55%, Ferguson et al. sites a 9.1% metastatic rate in BCC of the NAC.2,4 Although BCC of the NAC is rare, its incidence is increasing and the diagnosis harbors a greater risk for morbidity and mortality.5 Consequently, BCC should be included in the differential for an undiagnosed lesion on the NAC.

DISCLOSURES

The authors have not disclosed any relevant conflicts.

REFERENCES

  1. Kwasniak LA, Garcia-Zuazaga J. Basal cell carcinoma: evidence-based medicine and review of treatment modalities. Int J Dermatol. 2011;50(6):645–658.
  2. Wong CS, Strange RC, Lear JT. Basal cell carcinoma. BMJ. 2003;327:794–798.
  3. Ferguson MS, Nouraei SA, Davies BJ, McLean NR. Basal cell carcinoma of the nipple-areola complex. Dermatol Surg. 2009;35:1771– 1775.
  4. Sinha A, Langtry JAA. Secondary intention healing following mohs micrographic surgery for basal cell carcinoma of the nipple and areola. Acta Dermato-Venereologica. 2011;91(1):78–79.
  5. Oramin Y, Demirkesen C, Akkaya AD, Koyuncu E. Basal Cell Carcinoma of the Nipple: An Uncommon but Ever-Increasing Location. Case Rep Dermatol Med. 2011; 2011:3 pages. Article ID 818291.

AUTHOR CORRESPONDENCE

Lindsey Goddard BBALindsey-Goddard@ouhsc.edu
Close Menu